Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Credit
Loan against securities and Personal loan
Manage alerts
Active alerts for Jenburkt Pharma
Add new alert
JENBURPH •
NSE
Jenburkt Pharmaceuticals
₹1,038.80
7.30 (0.71%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
BSE •
12 hours ago
Jenburkt Pharmaceuticals reappoints Shri Dilip H. Bhuta as Whole Time Director & CFO for 5 years from Apr 2027 to Mar 2032. Shareholders approved his tenure extension and remuneration for 3 years; details available on company website.
BSE •
12 hours ago
Jenburkt Pharmaceuticals' AGM approved all resolutions with requisite majority, including dividend declaration and director reappointments. Voting results and scrutinizer's report are accessible on company and NSDL websites; resolutions included cost auditor remuneration ratification.
BSE •
21 hours ago
Jenburkt Pharma elevates Prem Ashish Bhuta to AVP-Strategic Initiatives effective 4th Sep 2026. Bhuta, with 5 years' pharma experience, aided ZIXA Strong launch and tech modernization efforts.
Equity Bulls •
4 months ago
Jenburkt Pharmaceuticals recommends Rs. 20.70 dividend per Rs. 10 equity share for FY25-26. Stock traded at Rs. 1074.5, with intraday high of Rs. 1119.2 and turnover of Rs. 27.2L.
BSE •
4 months ago
Jenburkt Pharmaceuticals' Board approved FY26 audited financials, reporting revenue of ₹17,904L and net profit of ₹3,474L. A dividend of ₹220.7/share was declared, and Dilip H. Bhuta reappointed as Whole-Time Director & CFO for five years.